Search Results 1591-1600 of 17154 for monoclonal antibody

1. Efficacy and Safety of ISIS-TTR Rx in Familial Amyloid Polyneuropathy - Mayo Clinic

   Known monoclonal gammopathy of undetermined significance or multiple myeloma; Other causes of sensorimotor or autonomic neuropathy (e.g., autoimmune disease) ...

2. Safety and Efficacy of bb2121 (Ide-cel) Combinations in Multiple Myeloma - Mayo Clinic

   Subject has received prior treatment with an immunomodulatory agent, a proteasome inhibitor and an anti-CD38 antibody-containing regimen for at least 2 ...

3. Intrathecally Administered Gene Therapy APB-102 in Rapidly Progressive ALS Patients with SOD1 Mutations - Mayo Clinic

   Titer for neutralizing antibodies (NAb) to AAV rh10 > [1:50] at Screening ... antibody (anti-HCV) or hepatitis B surface antigen (HBsAg); or who have ...

4. Dose Escalation Study of mRNA-2752 for Intratumoral Injection to Participants in Advanced Malignancies - Mayo Clinic

   hepatitis B core antibody [anti-HBc] and absence of HBsAg) are eligible. Participants positive for hepatitis C (HCV) antibody are eligible only if polymerase ...

5. Neurosciences Clinical Trials - Medical Professionals - Mayo Clinic

   The purpose of the study is to learn more about autoimmunity and potential mother to baby transmission of pathogenic antibodies. The collected research ...

6. MDM2 Inhibitor AMG-232 and Radiation Therapy in Treating Patients With Soft Tissue Sarcoma - Mayo Clinic

   Patients with known Positive Hepatitis B Surface Antigen (HepBsAg) (indicative of chronic Hepatitis B), positive Hepatitis total core antibody with negative ...

7. A Study of R-ICE and Lenalidomide for Treating Patients with First-Relapse/Primary Refractory Diffuse Large B-Cell Lymphoma - Mayo Clinic

   Subjects with hepatitis C antibody will be eligible provided that they do not have elevated liver transaminases or other evidence of active hepatitis ...

8. A Phase Ib/II Study of BYL719 and Cetuximab in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma - Mayo Clinic

   ... antibody therapy is allowed regardless of the prior treatment settings. For Phase II, Arms 1 and 2, prior cetuximab or other EGFR-targeted antibody ...

9. Mayo Clinic Biobank - Autoimmune Disorders

   ... antibodies can differentiate inflammatory bowel disease from healthy ... Camilleri, M.D., is working to develop a new test to detect a specific antibody ...

10. Meningococcal vaccine (intramuscular route) - Side effects & uses - Mayo Clinic

    The vaccine works by causing your body to produce its own protection (antibodies) against the disease. Meningococcal infection can cause life-threatening ...